|
US2009074885A1
|
|
Reversible Hydrophobic Modification of Drugs for Improved Delivery to Cells
|
|
US2008287630A1
|
|
Endosomolytic poly(acrylate) polymers
|
|
US2008287628A1
|
|
Endosomolytic poly(vinyl ether) polymers
|
|
US2007244067A1
|
|
Devices and processes for distribution of genetic material to mammalian limb
|
|
US7803782B2
|
|
Intravenous delivery of polynucleotides to cells in mammalian limb
|
|
US7816337B2
|
|
Reversible attachment of a membrane active polymer to a polynucleotide
|
|
US7682626B2
|
|
Polyvinylethers for delivery of polynucleotides to mammalian cells
|
|
US2004157790A1
|
|
Process for delivering sirna to cardiac muscle tissue
|
|
US7871818B2
|
|
Membrane active polymers
|
|
US2010120152A1
|
|
Methods for expression of transgenes
|
|
US7507722B1
|
|
Intravascular delivery of nucleic acid
|
